AMLX R&D Expense Growth
Amylyx Pharmaceuticals Inc · R&D Expense Growth
AMLX R&D Expense Growth
Latest reported-13.14%period ending
AMLX FY R&D Growth (YoY) (0.00% → -13.14%)
Latest values, visible window
High-resolution chart · PNG
AMLX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -13.1432% | |
| -18.803% | |
| 37.1717% | |
| 112.1935% | |
| 79.0681% | |
| 106.6896% | |
| 0% |